Monitor for a de-SPAC target announcement, which is the primary catalyst for BREZ. The $140M trust is a blank-check vehicle with no operating business — valuation and sector focus will drive stock performance upon deal announcement.
Price Chart
Executive Summary
Breeze Acquisition Corp. II closed the partial exercise of the underwriters' over-allotment option, selling an additional 1,500,000 units at $10.00 per unit, bringing the total IPO to 14,000,000 units. The units began trading on May 13, 2026, and the net proceeds will fund a future business combination in healthcare, biotech, or advanced tech sectors.
Key Financial Metrics
Key Facts
- Over-allotment option partially exercised: 1,500,000 additional units sold at $10.00/unit
- Total IPO size: 14,000,000 units
- Units began trading on Nasdaq under BREZU on May 13, 2026
- Each unit consists of one ordinary share and one right (1/5 share per right upon business combination)
- Net proceeds will fund an initial business combination in healthcare, biotech, advanced manufacturing, robotics, AI, or related sectors
- IB Capital LLC and I-Bankers Securities, Inc. acted as book-running managers
Financial Impact
Additional $15.0 million raised from over-allotment exercise, total IPO gross proceeds approximately $140.0 million
Risk Factors
- No identified acquisition target yet — risk of failing to complete a business combination within 24 months
- Dilution from rights and potential sponsor promote upon de-SPAC
- SPAC market headwinds and regulatory scrutiny may limit deal quality or shareholder approval
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296127 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 15, 2026 23w ago | Press Release | — | awaiting T+20 | — | — |
May 13, 2026 23w ago | EFFECT | — | awaiting T+20 | — | — |
May 12, 2026 23w ago | Press Release | — | awaiting T+20 | — | — |
May 12, 2026 23w ago | 3 | — | awaiting T+20 | — | — |
Mar 9, 2026 33w ago | S-1/A | — | awaiting T+20 | — | — |
Mar 3, 2026 34w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers